Valneva SE (VALN) Payables (2020 - 2026)
Valneva SE (VALN) posted quarterly Payables of $24.8 million for Q1 2026, down 21.66% year-on-year from $31.7 million in Q1 2025, and down 11.14% on a QoQ basis from $27.9 million in Q4 2025.
Valneva SE (VALN) Payables (2020 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Payables for 7 consecutive years, with $24.8 million the latest figure, recorded in Q1 2026.
- Quarterly Payables fell 21.66% year-over-year to $24.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.8 million (down 21.66% YoY) and the FY2025 annual result came in at $27.9 million, down 30.92% from the prior year.
- Payables fell to $24.8 million in Q1 2026 per VALN's latest filing, from $27.9 million in the prior quarter.
- Over the last five years, Payables for VALN reached as high as $108.4 million in Q2 2022 and fell as low as $24.0 million in Q2 2025.
- A 5-year average of $56.2 million and a median of $48.8 million in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables gained 7.74% — and 2024, when it tumbled 54.48%.
- Year by year, Payables stood at $60.4 million in 2022, then fell by 16.52% to $50.4 million in 2023, then slipped by 19.82% to $40.4 million in 2024, then sank by 30.92% to $27.9 million in 2025, then declined by 11.14% to $24.8 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $24.8 million, $27.9 million, and $34.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | 24.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.81 Mn |
| Dec 31, 2025 | 27.93 Mn |
| Sep 30, 2025 | 34.27 Mn |
| Jun 30, 2025 | 24.03 Mn |
| Mar 31, 2025 | 31.67 Mn |
| Dec 31, 2024 | 40.42 Mn |
| Sep 30, 2024 | 48.81 Mn |
| Jun 30, 2024 | 37.15 Mn |
| Mar 31, 2024 | 38.13 Mn |
| Dec 31, 2023 | 50.41 Mn |
| Sep 30, 2023 | 107.24 Mn |
| Jun 30, 2023 | 78.69 Mn |
| Mar 31, 2023 | 54.25 Mn |
| Dec 31, 2022 | 60.39 Mn |
| Sep 30, 2022 | 99.53 Mn |
| Jun 30, 2022 | 108.39 Mn |
| Mar 31, 2022 | 88.76 Mn |
| Dec 31, 2021 | 85.60 Mn |
| Dec 31, 2020 | 49.16 Mn |